Product Description
| Cat Number | IG-050 |
|---|---|
| Category | Peptide |
| Pack Size | 1 mg |
| Description | Syndecan-1 mediated integrin activation inhibitor |
| Modification | None |
| Purity | >95% by hplc |
| Biomarker Target | Protein-protein interactions,Integrin receptors |
| Sequence Three Letter Code | H-Leu-Pro-Ala-Gly-Glu-Lys-Pro-Glu-Glu-Gly-Glu-Pro-Val-Leu-His-Val-Glu-Ala-Glu-Pro-Gly-Phe-Thr-Ala-Arg-Asp-Lys-Glu-OH |
| Molecular Formula | C133H207N35O46 |
| Sl Sequence | LPAGEKPEEGEPVLHVEAEPGFTARDKE |
| Solubility | Soluble in water |
| Appearance | Freeze dried solid |
| Storage | Store dry, frozen and in the dark |
| References |
Beauvais et al (2009) Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor. J Exp Med. 206(3) 691 PMID: 19255147Rapraeger (2013) Synstatin: a selective inhibitor of the syndecan-1-coupled IGF1R-αvβ3 integrin complex in tumorigenesis and angiogenesis. FEBS J. 280(10) 2207 PMID: 23375101 Related areasAll peptides >All integrin receptor modulators >All protein-protein modulators >All cancer research categories > |
| Note | The product is for research use only |
Share Item: